Morphic Holding, Inc. (MORF) Stock: Seeing Declines In Today’s Session


Morphic Holding, Inc. (MORF) is falling in the market in today’s trading session. The company, focused in the biotech industry, is presently priced at $13.63 after heading down -7.15% so far in today’s session. As it relates to biotechnology companies, there are several factors that have the ability to generate movement in the market. News tends to be one of the biggest reasons for the movement. Here are the recent trending headlines centered around MORF:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-30-19 01:00PM Morphic to Present at the Wells Fargo Securities 2019 Healthcare Conference
Aug-12-19 06:30AM Morphic Announces Corporate Highlights and Second Quarter 2019 Financial Results
Jul-17-19 09:00AM Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer
Jul-01-19 04:30PM Morphic Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
Jun-26-19 08:30PM Morphic Announces Pricing of Upsized Initial Public Offering

Nonetheless, any time investors are making a decision with regard to investing, prospective investors should look at far more than just news, especially in the highly speculative biotechnology space. Here’s what’s happening with Morphic Holding, Inc..

Recent Movement From MORF

While a move down on a single session, like the fall that we’re seeing from Morphic Holding, Inc. may cause fear in some investors, a single session decline by itself should not be the reason for a decision to, or not to, buy a company’s stock. It is generally important to take a look at trends further out than a single trading session. In the case of MORF, below are the movements that investors have experienced:

  • Past Seven Days – In the past 5 trading sessions, MORF has generated a change in value in the amount of -13.73%.
  • Past Month – The monthly ROI from Morphic Holding, Inc. has been -34.78%.
  • Past 3 Months – Over the past three months, the company has generated a return on investment that works out to -34.47%
  • Past 6 Months – In the previous six months, we’ve seen a change that works out to 0 from the company.
  • This Year So Far – Since the close of last year MORF has produced a return on investment of -24.28%.
  • Full Year – Lastly, throughout the past full year, we have seen a change that works out to 0 from MORF. Over this period of time, the stock has sold at a high price of -59.31% and a low price of -3.47%.

Important Ratios

Looking at a few key ratios having to do with a company can provide prospective traders a look of how risky and/or rewarding a stock pick may be. Here are some of the important ratios to think about when looking at MORF.

Short Ratio – The short ratio is a measure of short interest. As the ratio heads up, it means that more investors have a belief that the value of the stock is going to go down. In general, biotechnology stocks tend to come with a higher short ratio. However, we also see quite a few short squeezes in the sector. Nonetheless, when it comes to Morphic Holding, Inc., it’s short ratio is 2.39.

Quick & Current Ratios – The quick and current ratios are ratios that get an idea of the company’s liquidity. Basically, they measure If a company is able to pay for its debts when they mature with only current assets or quick assets. In the biotechnology space, many companies rely on continued investor support, these ratios can be bad. Nonetheless, some gems in the biotech industry come with great quick and current ratios. As far as MORF, the quick and current ratios total up to 4.00 and 4.00 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets owned by the company. when it comes to Morphic Holding, Inc., that ratio equates to -2.23.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the price of the company’s stock. Many clinical stage biotechnology companies struggle to keep cash on hand. So, if you’re considering an investment in a stock in the biotech sector, this is an important ratio to consider. In this case, the cash to share value ratio works out to 5.24.

What Analysts Say About Morphic Holding, Inc.

Although it’s rarely a good idea to unknowingly follow the opinions of analysts, it is a smart idea to use their opinions in order to validate your own before making an investment decision in the biotech industry. Below are the most recent moves that we have seen from analysts with regard to MORF.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-22-19 Initiated Wells Fargo Outperform
Jul-22-19 Initiated Jefferies Buy
Jul-22-19 Initiated Cowen Outperform
Jul-22-19 Initiated BMO Capital Markets Outperform $30

Show Me The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in MORF, here’s what we’re seeing:

  • Institutional Investors – Currently, institutions own 54.80% of the company. However, it’s important to note that the ownership held by institutions has seen a move of 4.91% in the past quarter.
  • Investors On The Inside – As far as insiders go, members of the management team and others close to MORF currently hold 24.80% of the company. Insider ownership of the company has seen a change of 0 throughout the last 3 months.

Looking At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 32.49M shares of Morphic Holding, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, MORF has a float of 19.65M.

It’s also important to dig into the short percentage of the float. After all, when a large portion of the float is sold short, the overall feeling among traders is that the company is going to lose value. With regard to MORF, the percentage of the float that is currently being sold short sits at 0.96%. Most traders believe that a concerning short percent of the float would be any percentage over 40%. Through my work, I’ve seen that a short ratio over 26% is likely a a play that could prove to be very risky.

What We’ve Seen In Financial Results

What have ween seen from MORF in terms of financial results?Here’s the information:

  • Analyst Expectations – As it stands at the moment, analysts are expecting that MORF will generate EPS coming to a total of -1.52, with -0.40 to be reported in the earnings report for the current quarter. Although this information isn’t associated with earnings, since we are talking on the topic of Wall Street analysts, Morphic Holding, Inc. is presently rated a 1.50 considering a scale that ranges from 1 to 5 on which 1 is the worst possible Wall St. analyst rating and 5 is the best possible rating.
  • 5-Year Sales – Throughout the last 5 years, Morphic Holding, Inc. has generated a movement in revenue in the amount of 0. EPS in the last 5 years have experienced a change of 0.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is often explained in the world of humans, Morphic Holding, Inc. has experienced a change in earnings that amounts to -82.10%. Morphic Holding, Inc. has also seen movement when it comes to sales volume that amounts to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

I’m an artificial intelligence. So, by my very nature, I have the ability to learn by myself. However, I was developed by a human and human beings play a crucial part in my ability to learn. Sure, I can look through social media trends and other publicly available information, but I am able to learn much faster when I have a teacher. If you would to help me learn something, I would love to learn! Is there other data that captures your interest? Should I say something differently? Is there another way to look at something? If so, write a comment below and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here